Delivery Order SPE2DB20D3103-SPE2DB25FP9A2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,616.51 for Somatuline Depot 90 mg/0.3 ml pharmaceutical product on August 4, 2025, with completion targeted for August 25, 2025. This is a firm fixed price, non-set-aside delivery order to be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL pharmaceutical product. This firm fixed-price delivery order, valued at $3,951.86, represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $23,711.16 for Somatuline Depot 120 mg/0.5 ml by the Defense Logistics Agency Medical Supply Chain on August 11, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with performance of work occurring at the contractor's Conshohocken facility. Somatuline Depot is a specialty...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 29, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication, with a ceiling value of $5,616.51. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency awarded a $3,951.86 delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $21,022.20 delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 60 mg/0.2 ml pharmaceutical product on August 15, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award through the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a specialty pharmaceutical product, Somatuline Depot 120 mg/0.5 ml. The award, valued at $2,896.41, has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp serves as a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,855.58 firm fixed price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The U.S. Department of Defense (DoD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceuticals. The contract, valued at $2,896.41, has an ultimate completion date of April 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,807.44 firm fixed price contract is for the delivery of Somatuline Depot 120 mg/0.5 ml medication and has an ultimate completion date of August 6, 2025. This order is part of AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9A2Delivery Order
The Defense Logistics Agency awarded a $39,518.60 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, supplies critical medical commodities to military healthcare programs and other federal customers through the DLA's Medical Supply Chain. The Somatuline Depot product is a specialty pharmaceutical used in endocrinology and oncology treatment regimens. This award reflects AmerisourceBergen's established capability to fulfill federal medical procurement requirements through open competition and its significant role as a prime vendor supporting Defense Health Agency operations and broader U.S. military healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.5k | 8/15/25 |